4.4 Article

Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma

Related references

Note: Only part of the references are listed.
Article Pathology

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

Kiril Trpkov et al.

Summary: The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal neoplasia, emphasizing the diagnostic criteria and key prognostic features for different types of renal tumors. They also proposed new nomenclature and classification recommendations for some novel variants.

MODERN PATHOLOGY (2021)

Article Pathology

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients

Hubert D. Lau et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Article Pathology

Renal Medullary Carcinoma Molecular, Immunohistochemistry, and Morphologic Correlation

Qingyan Liu et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Article Cell Biology

SMARCB1/INI1 inactivation in renal medullary carcinoma

Julien Calderaro et al.

HISTOPATHOLOGY (2012)

Article Pathology

The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome

Maria J. Merino et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Article Urology & Nephrology

Collecting duct renal cell carcinoma: A matched analysis of 41 cases

Pierre I. Karakiewicz et al.

EUROPEAN UROLOGY (2007)

Article Pathology

Renal medullary carcinoma: report of seven cases from Brazil

Isabela C. Watanabe et al.

MODERN PATHOLOGY (2007)